XOLAIR omalizumab (rch) 300 mg solution for injection pre-filled syringe (2025-26)
Product name
XOLAIR omalizumab (rch) 300 mg solution for injection pre-filled syringe
Sponsor name
Novartis Pharmaceuticals Australia Pty Ltd
Year Range
2025-26